Correlation Between X4 Pharmaceuticals and Allarity Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Allarity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Allarity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Allarity Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Allarity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Allarity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Allarity Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and Allarity Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between XFOR and Allarity is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Allarity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allarity Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Allarity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allarity Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Allarity Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Allarity Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 0.96 times more return on investment than Allarity Therapeutics. However, X4 Pharmaceuticals is 1.04 times less risky than Allarity Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Allarity Therapeutics is currently generating about -0.27 per unit of risk. If you would invest 219.00 in X4 Pharmaceuticals on August 27, 2024 and sell it today you would lose (185.00) from holding X4 Pharmaceuticals or give up 84.47% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
X4 Pharmaceuticals vs. Allarity Therapeutics
Performance |
Timeline |
X4 Pharmaceuticals |
Allarity Therapeutics |
X4 Pharmaceuticals and Allarity Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with X4 Pharmaceuticals and Allarity Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and Allarity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Allarity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will offset losses from the drop in Allarity Therapeutics' long position.X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |